Second, Savinov et al. [87] have shown that MMP-26 up-regulation in breast ductal carcinoma in situ correlates with longer patient survival, perhaps due to the intracellular cleavage of ER-beta by this protease. The gene discussed is MMP26; the disease is ductal breast carcinoma in situ.